Serum cystatin C, a new marker of glomerular filtration rate, is increased during malignant progression
about
Acute kidney injury 2016: diagnosis and diagnostic workupAssociation Between Serum Cystatin C and Creatinine in Chronic Kidney Disease Subjects Attending a Tertiary Health Care CentreCystatin C in acute kidney injury diagnosis: early biomarker or alternative to serum creatinine?Serum Beta 2-microglobulin/cystatin C index: a useful biomarker in lupus nephritis?Cystatin C--a paradigm of evidence based laboratory medicine.Cystatin-C is an independent prognostic factor for survival in multiple myeloma and is reduced by bortezomib administration.Differential secreted proteome approach in murine model for candidate biomarker discovery in colon cancer.Evaluation of serum cystatin-C and symmetric dimethylarginine concentrations in dogs with heart failure from chronic mitral valvular insufficiency.Proteomic analysis of bronchoalveolar lavage fluid (BALF) from lung cancer patients using label-free mass spectrometry.Biomarkers for the prediction of acute kidney injury: a narrative review on current status and future challenges.Cystatins in immune system.New Model for Estimating Glomerular Filtration Rate in Patients With Cancer.Correlation between cystatin C-based formulas, Schwartz formula and urinary creatinine clearance for glomerular filtration rate estimation in children with kidney disease.Lessons on Tumour Response: Imaging during Therapy with (177)Lu-DOTA-octreotate. A Case Report on a Patient with a Large Volume of Poorly Differentiated Neuroendocrine Carcinoma.
P2860
Q28066260-BA7EDC51-ADEB-449D-BE19-9F03D98ED62FQ33741494-0F704297-4034-49DC-90BD-BB1DDFB466B1Q35212922-AD8EDD83-22CD-445D-BF97-C4B698435F68Q36100610-7006B65E-6F72-4FCC-A599-5E6D55968713Q36869663-3FD431F1-8AB2-4F3A-ACA5-7BE2EBF2FA80Q37112901-557641AB-4D4F-413B-A6FD-5AF02DC5967AQ37441231-B4471B71-145B-4A8E-80B9-642A9DDFCE57Q37621317-3E815AD2-903D-4607-852A-448A6ABFBF31Q37710444-AE62E90B-7DB6-4F2D-8316-388B48F41FEBQ38029606-EF1020C9-0495-43E3-9BA6-2C7A4AF18F97Q38079586-56E54D66-377E-43D7-AF03-98534FD875DBQ38689410-40CD2C5C-F2FC-47DA-98BA-DE161B4859E0Q41205172-65EE669C-24F3-4CDD-8E53-39A788339222Q42177470-07790BF7-5D49-4031-97EF-C79484FC82C2
P2860
Serum cystatin C, a new marker of glomerular filtration rate, is increased during malignant progression
description
1998 nî lūn-bûn
@nan
1998 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Serum cystatin C, a new marker ...... d during malignant progression
@ast
Serum cystatin C, a new marker ...... d during malignant progression
@en
Serum cystatin C, a new marker ...... d during malignant progression
@nl
type
label
Serum cystatin C, a new marker ...... d during malignant progression
@ast
Serum cystatin C, a new marker ...... d during malignant progression
@en
Serum cystatin C, a new marker ...... d during malignant progression
@nl
prefLabel
Serum cystatin C, a new marker ...... d during malignant progression
@ast
Serum cystatin C, a new marker ...... d during malignant progression
@en
Serum cystatin C, a new marker ...... d during malignant progression
@nl
P2093
P3181
P1433
P1476
Serum cystatin C, a new marker ...... d during malignant progression
@en
P2093
P304
P3181
P407
P577
1998-12-01T00:00:00Z